Raf Mols

4.1k total citations
53 papers, 2.8k citations indexed

About

Raf Mols is a scholar working on Oncology, Pharmaceutical Science and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Raf Mols has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pharmaceutical Science and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Raf Mols's work include Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (15 papers) and Advanced Drug Delivery Systems (9 papers). Raf Mols is often cited by papers focused on Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (15 papers) and Advanced Drug Delivery Systems (9 papers). Raf Mols collaborates with scholars based in Belgium, United States and Germany. Raf Mols's co-authors include Patrick Augustijns, Pieter Annaert, Eric Schoenmakers, Jörn Bullerdiek, Jan Tack, Sylke Wanschura, Wim J.M. Van de Ven, Herman Van den Berghe, Joachim Brouwers and Jan Van Humbeeck and has published in prestigious journals such as Nature Communications, Nature Genetics and Gastroenterology.

In The Last Decade

Raf Mols

53 papers receiving 2.7k citations

Peers

Countries citing papers authored by Raf Mols

Since Specialization

Citations

This map shows the geographic impact of Raf Mols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raf Mols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raf Mols more than expected).

Fields of papers citing papers by Raf Mols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raf Mols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raf Mols. The network helps show where Raf Mols may publish in the future.

Co-authorship network of co-authors of Raf Mols

This figure shows the co-authorship network connecting the top 25 collaborators of Raf Mols. A scholar is included among the top collaborators of Raf Mols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raf Mols. Raf Mols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	β-D-N4-hydroxycytidine (NHC, EIDD-1931) inhibits chikungunya virus replication in mosquito cells and ex vivo Aedes aegypti guts, but not when ingested during blood-feeding 2024 ·Antiviral Research ·(unknown), (unknown), Lanjiao Wang, Raf Mols, Albin Fontaine, (unknown), Patrick Augustijns, Leen Delang	1
2	Effect of sleeve gastrectomy and Roux-en-Y gastric bypass on gastrointestinal physiology 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Nele Steenackers, Tim Vanuytsel, Patrick Augustijns, (unknown), Wies Deckers, Christophe M. Deroose, Gwen Falony, Matthias Lannoo, Ann Mertens, Raf Mols, Roman Vangoitsenhoven, Lucas Wauters, Bart Van der Schueren, Christophe Matthys	9
3	Characterization of neonatal and infant enterostomy fluids 2023 ·International Journal of Pharmaceutics ·(unknown), Joachim Brouwers, Raf Mols, Ilse Hoffman, Maissa Rayyan, Patrick Augustijns	6
4	Investigating the Mechanisms behind the Positive Food Effect of Abiraterone Acetate: In Vitro and Rat In Situ Studies 2022 ·Pharmaceutics ·(unknown), Patrick Augustijns, Raf Mols, (unknown), Joachim Brouwers	8
5	Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia 2021 ·International Journal of Molecular Sciences ·Lucas Wauters, Raúl Y. Tito, Matthias Ceulemans, (unknown), Alison Accarie, Leen Rymenans, Chloë Verspecht, Joran Tóth, Raf Mols, Patrick Augustijns, Jan Tack, Tim Vanuytsel, Jeroen Raes	32
6	Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134” 2020 ·Pharmaceutics ·Anallely López‐Yerena, Anna Vallverdú‐Queralt, Raf Mols, Patrick Augustijns, Rosa M. Lamuela‐Raventós, Elvira Escribano‐Ferrer	6
7	Codeine delays gastric emptying through inhibition of gastric motility as assessed with a novel diagnostic intragastric balloon catheter 2019 ·Neurogastroenterology & Motility ·(unknown), Jan de Hoon, John Morales, Carolina Varon, Sabine Van Huffel, Patrick Augustijns, Raf Mols, (unknown), Kristin Verbeke, Tim Vanuytsel, Jan Tack, Pieter Janssen	16
8	Exploring gastric drug absorption in fasted and fed state rats 2018 ·International Journal of Pharmaceutics ·Jari Rubbens, Raf Mols, Joachim Brouwers, Patrick Augustijns	20
9	Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools 2017 ·Molecular Pharmaceutics ·Jens Van Den Αbeele, Ronald Schilderink, Felix Schneider, Raf Mols, Mans Minekus, Werner Weitschies, Joachim Brouwers, Jan Tack, Patrick Augustijns	29
10	Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area 2015 ·The Pediatric Infectious Disease Journal ·Kim Vanstraelen, Anca Coliţă, (unknown), Raf Mols, Patrick Augustijns, Nele Peersman, Pieter Vermeersch, Pieter Annaert, Isabel Spriet	34
11	Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions 2015 ·Journal of Pharmaceutical Sciences ·Danny Riethorst, Raf Mols, Guus Duchateau, Jan Tack, Joachim Brouwers, Patrick Augustijns	203
12	Intestinal behavior of the ester prodrug tenofovir DF in humans 2015 ·International Journal of Pharmaceutics ·(unknown), Steven Haenen, Raf Mols, Joachim Brouwers, Jan Tack, Pieter Annaert, Patrick Augustijns	26
13	Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine 2013 ·European Journal of Pharmaceutical Sciences ·Nico Holmstock, Tom De Bruyn, Jan Bevernage, Pieter Annaert, Raf Mols, Jan Tack, Patrick Augustijns	48
14	The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate 2011 ·International Journal of Pharmaceutics ·Thao Do Thi, Michiel Van Speybroeck, Raf Mols, Pieter Annaert, Johan A. Martens, Jan Van Humbeeck, Jan Vermant, Patrick Augustijns, Guy Van den Mooter	53
15	Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling 2010 ·Biopharmaceutics & Drug Disposition ·Joachim Brouwers, Raf Mols, Pieter Annaert, Patrick Augustijns	16
16	INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE 2009 ·Drug Metabolism and Disposition ·Raf Mols, Joachim Brouwers, Alfred H. Schinkel, Pieter Annaert, Patrick Augustijns	33
17	Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·Randy Mellaerts, Raf Mols, Jasper Jammaer, Caroline Aerts, Pieter Annaert, Jan Van Humbeeck, Guy Van den Mooter, Patrick Augustijns, Johan A. Martens	199
18	HPLC with programmed wavelength fluorescence detection for the simultaneous determination of marker compounds of integrity and P-gp functionality in the Caco-2 intestinal absorption model 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·Patrick Augustijns, Raf Mols	40
19	Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours 1995 ·Nature Genetics ·Eric Schoenmakers, Sylke Wanschura, Raf Mols, Jörn Bullerdiek, Herman Van den Berghe, Wim J.M. Van de Ven	475
20	Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas 1994 ·Genes Chromosomes and Cancer ·Eric Schoenmakers, Raf Mols, Sylke Wanschura, Patrick Kools, Jan M.W. Geurts, Sabine Bartnitzke, Jörn Bullerdiek, (unknown), (unknown)	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact